Bispecific antibodies (bsAbs) exert their function through diverse strategies including T-cell engagement for immune-mediated tumor cell killing, dual immune checkpoint inhibition to enhance immune ...

Elinzanetant, a dual NK-1 and NK-3 receptor antagonist, effectively reduces VMS and sleep disturbances in menopause. It offers a nonhormonal alternative to therapies associated with cancer and ...

New topline data from the MINT trial (NCT04524273), which is investigating inebilizumab in patients with generalized myasthenia gravis who are acetylcholine receptor (AChR) antibody or muscle ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

in adult patients who are anti-acetylcholine receptor (AchR) antibody positive. EPYSQLI will be offered at a 30% discount of the Wholesale Acquisition Cost (WAC) of the reference product, Soliris ®, ...

atypical hemolytic uremic syndrome and generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive. EPYSQLI will be offered at a 30% discount of the ...

in adult patients who are anti-acetylcholine receptor (AchR) antibody positive. In July 2024, the FDA approved EPYSQLI as a biosimilar to Soliris to treat patients with PNH to reduce hemolysis, and ...

PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced positive topline results from its ...

atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine receptor antibody positiveEPYSQLI will be available at a 30% discount of the Wholesale ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Glioblastoma multiforme (GBM) is the most ...

protein receptor-binding domain (RBD) chimeric from different lineages fused with Fc fragments. Results: In mice and non-human primates, RBDco effectively induced neutralizing antibodies against ...